BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21361031)

  • 1. [Neurodegenerative conformational disease and heat shock proteins].
    Kong XC; Bao XQ; Liu GT
    Yao Xue Xue Bao; 2010 Nov; 45(11):1333-8. PubMed ID: 21361031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein folding and misfolding in the neurodegenerative disorders: a review.
    Bolshette NB; Thakur KK; Bidkar AP; Trandafir C; Kumar P; Gogoi R
    Rev Neurol (Paris); 2014 Mar; 170(3):151-61. PubMed ID: 24613386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein degradation, aggregation, and misfolding.
    Cuervo AM; Wong ES; Martinez-Vicente M
    Mov Disord; 2010; 25 Suppl 1():S49-54. PubMed ID: 20187257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurodegenerative disorders: the role of genetic factors in their origin and the efficiency of treatment].
    Sukhanov VA; Ionov ID; Piruzian LA
    Fiziol Cheloveka; 2005; 31(4):119-30. PubMed ID: 16122046
    [No Abstract]   [Full Text] [Related]  

  • 10. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The ubiquitin-proteasome system and neurodegenerative disease].
    Tanaka K
    No To Shinkei; 2001 Oct; 53(10):935-42. PubMed ID: 11725503
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology].
    Shelkovnikova TA; Kulikova AA; Tsvetkov FO; Peters O; Bachurin SO; Bukhman VL; Ninkina NN
    Mol Biol (Mosk); 2012; 46(3):402-15. PubMed ID: 22888630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
    Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
    Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing therapeutics for the diseases of protein misfolding.
    May BC; Govaerts C; Cohen FE
    Neurology; 2006 Jan; 66(2 Suppl 1):S118-22. PubMed ID: 16432139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?
    Ross JM; Olson L; Coppotelli G
    Int J Mol Sci; 2015 Aug; 16(8):19458-76. PubMed ID: 26287188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.